These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2516138)

  • 21. Discrepancy between initial and steady-state resistance vessel responsiveness to short-term nitroglycerin exposure in the hindlimb of conscious dogs.
    Stewart DJ; Münzel T; Holtz J; Bassenge E
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):144-51. PubMed ID: 2459545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogs.
    Gaspo R; Lamarche L; Yamaguchi N; de Champlain J; Garceau D
    Can J Physiol Pharmacol; 1992 Jul; 70(7):983-9. PubMed ID: 1451037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered spectrum of nitroglycerin action in long-term treatment: nitroglycerin-specific venous tolerance with maintenance of arterial vasodepressor potency.
    Stewart DJ; Elsner D; Sommer O; Holtz J; Bassenge E
    Circulation; 1986 Sep; 74(3):573-82. PubMed ID: 3091286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the role of neural mechanisms in the cardiocirculatory inhibitory action of alpha-human atrial natriuretic peptide in the anesthetized rabbit.
    Tallarida G; Iellamo F; Raimondi G; Legramante JM; Cassarino S; Marazza D; Di Nardo P; Peruzzi G
    J Hypertens; 1991 Oct; 9(10):935-45. PubMed ID: 1658136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MCI-154, a novel cardiotonic agent, on mean circulatory filling pressure in anesthetized dogs.
    Satoh N; Abe Y; Kitada Y; Narimatsu A; Tobe A
    Eur J Pharmacol; 1990 Jan; 175(3):317-22. PubMed ID: 2108868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneous effects of nitroglycerin on the conductance and resistance coronary arterial vasculature.
    Zhang J; Somers M; Cobb FR
    Am J Physiol; 1993 Jun; 264(6 Pt 2):H1960-8. PubMed ID: 8322926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 2-nicotinamidethyl nitrate (SG-75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs.
    Mizukami M; Tomoike H; Inouh T; Watanabe K; Kikuchi Y; Nakamura M
    Arzneimittelforschung; 1981; 31(8):1244-7. PubMed ID: 6457606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the cardiovascular effect of nitroglycerin related to the prostaglandin system in the dog?
    Sakai K; Akima M; Nakamura Y
    Eur J Pharmacol; 1983 Dec; 96(3-4):285-9. PubMed ID: 6426977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-NAME, nitric oxide and jejunal motility, blood flow and oxygen uptake in dogs.
    Alemayehu A; Lock KR; Coatney RW; Chou CC
    Br J Pharmacol; 1994 Jan; 111(1):205-12. PubMed ID: 8012697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vasopressin on the circulation and its baroreflex control in healthy men.
    Aylward PE; Floras JS; Leimbach WN; Abboud FM
    Circulation; 1986 Jun; 73(6):1145-54. PubMed ID: 3698249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of nitroglycerin, trimetazidine, verapamil and SK&F 24260 on venous return as revealed by the open-loop method in the dog.
    Taira N; Imai Y; Hiwatari M
    Jpn J Pharmacol; 1980 Aug; 30(4):449-61. PubMed ID: 6782315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms whereby propofol mediates peripheral vasodilation in humans. Sympathoinhibition or direct vascular relaxation?
    Robinson BJ; Ebert TJ; O'Brien TJ; Colinco MD; Muzi M
    Anesthesiology; 1997 Jan; 86(1):64-72. PubMed ID: 9009941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral dexmedetomidine preserves baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs.
    Devcic A; Schmeling WT; Kampine JP; Warltier DC
    Anesthesiology; 1994 Aug; 81(2):419-30. PubMed ID: 8053593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo atrial peptide-venodilation: minimal potency relative to nitroglycerin in dogs.
    Holtz J; Stewart DJ; Elsner D; Bassenge E
    Life Sci; 1986 Dec; 39(23):2177-84. PubMed ID: 2946916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin causes vasoconstriction during hemorrhage in baroreceptor-denervated dogs.
    Averill DB; Scher AM; Feigl EO
    Am J Physiol; 1983 Oct; 245(4):H667-73. PubMed ID: 6624936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of nitroglycerin and nitroprusside on vascular capacitance of anesthetized ganglion-blocked dogs.
    Ogilvie RI; Zborowska-Sluis D
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):574-80. PubMed ID: 1724535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mean circulatory pressure, reproducibility of its measurements and the effect of phenylephrine with a note on the effect of pentobarbital.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K; Banno S; Hayase S
    Jpn Circ J; 1975 Apr; 39(4):403-9. PubMed ID: 1121054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial prostaglandin E release by nitroglycerin and modification by indomethacin.
    Morcillio E; Reid PR; Dubin N; Ghodgaonkar R; Pitt B
    Am J Cardiol; 1980 Jan; 45(1):53-7. PubMed ID: 6766046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of vascular tolerance in conductance vessels after 48 hours of intravenous nitroglycerin in patients with coronary artery disease.
    Jeserich M; Münzel T; Pape L; Fischer C; Drexler H; Just H
    J Am Coll Cardiol; 1995 Jul; 26(1):50-6. PubMed ID: 7797775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.